drugset / Trial / NCT07164183
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
RandomizedParallel-groupOpen-labelTreatment
Summary
Prospective open-label randomized parallel groups study to compare efficacy and safety of Indinol Forto® 200 mg capsules and Visanne 2 mg tablets in treatment of endometriosis. This is phase 3 study, based on hypothesis of non-inferiority.
Timeline
- Start
- 2025-09-11
- Primary completion
- 2026-10
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dienogest | Small molecule | 2 mg | Oral |
| Subject | Indole-3-carbinol | Small molecule | 200 mg | Oral |